FDA grants broad orphan drug status to PTX, shoots share price up almost 30%
Clinical state oncology company Prescient Therapeutics (ASX: PTX) has received the US FDA’s Orphan Drug...
Clinical state oncology company Prescient Therapeutics (ASX: PTX) has received the US FDA’s Orphan Drug...
During the second World War, scientists noted that soldiers exposed to nitrogen mustard gas developed...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.